CoChat
Sign Up
Cited by 181Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery SystemsBarrier Structure and Function Studies

Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases

Open access
Masoudi Asil, Shima, Ahlawat, Jyoti, Guillama Barroso, Gileydis, Narayan, Mahesh·2020·Biomaterials Science
DOI 10.1039/d0bm00809ePMC PMC7439575
Open this paper in CoChat — free account

Abstract

The recent advances in applications of nanotechnology including the use of inorganic, polymeric, magnetic and carbon nanomaterials in drug delivery for treatment of neurodegenerative diseases are reported.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/d0bm00809e

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nanoparticles have substantial surface area-to-volume ratios, making them ideal for drug modification or attachment of detection probes.

    “They also have substantial surface area-to-volume ratios, which makes them ideal for drug modification or attachment of detection probes [32–34].”

    From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [34]

    The Carbon Nanomaterials section (page unavailable) says graphene nanoparticles can be functionalized to conjugate drugs and contrast agents to their surfaces. The paper also describes nanoparticle surface modification for imaging and therapy, but the passages do not attribute this capacity to a substantial surface-area-to-volume ratio or specifically discuss attaching detection probes. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 153 references couldn’t be matched to a known paper.

Research works printed but not linked: 144

  1. [1]Karthivashan G, Ganesan P, Park S-Y, Kim J-S and Choi D-K, Drug delivery, 2018, 25, 307– 320. 29350055 PMC6058502
  2. [2]Vijayan M and Reddy PH, Journal of Alzheimer’s Disease, 2016, 54, 427– 443. PMC5793908 27567871
  3. [3]Saeedi M, Eslamifar M, Khezri K and Dizaj SM, Biomedicine & Pharmacotherapy, 2019, 111, 666– 675. 30611991
  4. [4]Adams CF, Dickson AW, Kuiper J-H and Chari DM, Nanoscale, 2016, 8, 17869– 17880. 27714076
  5. [5]Dai X, Li Y and Zhong Y, Glob J Nanomed, 2018, 4, 001– 004.
  6. [7]Spuch C, Saida O and Navarro C, Recent patents on drug delivery & formulation, 2012, 6, 2– 18. 22272933
  7. [9]Re F, Gregori M and Masserini M, Maturitas, 2012, 73, 45– 51. 22261367
  8. [10]Sharma U, Badyal PN and Gupta S, Int J Pharmacol, 2015, 2, 60– 69.
  9. [11]Niu X, Chen J and Gao J, Asian Journal of Pharmaceutical Sciences, 2019, 14, 480– 496. 32104476 PMC7032222
  10. [12]De la Torre C and Ceña V, Pharmaceutics, 2018, 10, 190. PMC6321229 30336640
  11. [13]Serra A, Letunic I, Fortino V, Handy RD, Fadeel B, Tagliaferri R and Greco D, Scientific reports, 2019, 9, 1– 10. 30655578 PMC6336851
  12. [14]Siddiqi KS and Husen A, Journal of Trace Elements in Medicine and Biology, 2017, 40, 10– 23. 28159216
  13. [15]Siddiqi KS, Husen A, Sohrab SS and Yassin MO, Nanoscale research letters, 2018, 13, 231. 30097809 PMC6086777
  14. [16]Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L and Bernardino L, Journal of Controlled Release, 2016, 235, 34– 47. 27208862
  15. [17]Kumari A, Yadav SK and Yadav SC, Colloids and surfaces B: biointerfaces, 2010, 75, 1– 18. 19782542
  16. [18]Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou S-F, Chauhan A and Kanwar RK, Nanomedicine: Nanotechnology, Biology and Medicine, 2012, 8, 399– 414. 21889479
  17. [19]John AA, Subramanian AP, Vellayappan MV, Balaji A, Mohandas H and Jaganathan SK, International journal of nanomedicine, 2015, 10, 4267– 4277. 26170663 PMC4495782
  18. [20]Alyautdin R, Khalin I, Nafeeza MI, Haron MH and Kuznetsov D, International journal of nanomedicine, 2014, 9, 795– 811. 24550672 PMC3926460
  19. [21]Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K and Caruso F, Advanced Materials, 2018, 30, 1801362. 30066406
  20. [22]Ibrahim MM and Gabr MT, Neural regeneration research, 2019, 14, 437. 30539809 PMC6334608
  21. [23]Daniele S, Giacomelli C and Martini C, Biochemical pharmacology, 2018, 158, 207– 216. 30393045
  22. [24]Liu EY, Cali CP and Lee EB, Disease models & mechanisms, 2017, 10, 509– 518. 28468937 PMC5451173
  23. [25]Van Dam D and De Deyn PP, British journal of pharmacology, 2011, 164, 1285– 1300. 21371009 PMC3229762
  24. [26]Danysz W and Parsons CG, British journal of pharmacology, 2012, 167, 324– 352. 22646481 PMC3481041
  25. [27]Revett TJ, Baker GB, Jhamandas J and Kar S, Journal of psychiatry & neuroscience: JPN, 2013, 38, 6– 23. 22894822 PMC3529221
  26. [28]Mehta M, Adem A and Sabbagh M, International Journal of Alzheimer’s disease, 2012, 2012, 1– 8. PMC3246720 22216416
  27. [29]Jordão JF, Ayala-Grosso CA, Markham K, Huang Y, Chopra R, McLaurin J, Hynynen K and Aubert I, PloS one, 2010, 5. PMC2868024 20485502
  28. [30]Modi G, Pillay V and Choonara YE, Annals of the New York Academy of Sciences, 2010, 1184, 154– 172. 20146696
  29. [31]Rahaman ST, World Journal of Pharmaceutical Sciences, 2018, 2321– 3310.
  30. [32]Adams WR, PloS one, 2017, 12. PMC5708704 29190695
  31. [33]Adhikary RR, Sandbhor P and Banerjee R, ADMET and DMPK, 2015, 3, 155– 181.
  32. [34]Maiti P, Manna J and Dunbar GL, Translational neurodegeneration, 2017, 6, 28. 29090092 PMC5655877
  33. [35]Adam H, Gopinath SC, Arshad MM, Adam T and Hashim U, Process Biochemistry, 2019, 86, 32– 39.
  34. [36]Ansorena E, Casales E, Aranda A, Tamayo E, Garbayo E, Smerdou C, Blanco-Prieto MJ and Aymerich MS, International journal of pharmaceutics, 2013, 440, 19– 26. 22580212
  35. [37]Tiwari PC and Pal R, Dialogues in clinical neuroscience, 2017, 19, 71. 28566949 PMC5442366
  36. [38]André EM, Delcroix GJ, Kandalam S, Sindji L and Montero-Menei CN, Pharmaceutics, 2019, 11, 526. PMC6835496 31614758
  37. [39]Bernis ME, Babila JT, Breid S, Wüsten KA, Wüllner U and Tamgüney G, Acta neuropathologica communications, 2015, 3, 75. 26612754 PMC4660655
  38. [40]Jansen AH, Batenburg KL, Pecho-Vrieseling E and Reits EA, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2017, 1863, 793– 800. 28040507
  39. [41]Liu X.-g., Lu S, Liu D.-q., Zhang L, Zhang L.-x., Yu X.-l.and Liu R.-t., Brain research, 2019, 1707, 141– 153. 30481502
  40. [42]Ramaswamy S and Kordower JH, Neurobiology of disease, 2012, 48, 243– 254. 22222669
  41. [44]Aulić S, Bolognesi ML and Legname G, International journal of cell biology, 2013, 2013. PMC3845517 24324497
  42. [45]Birks JS and Evans JG, Cochrane Database of systematic reviews, 2015, CD001191. 25858345
  43. [46]Erickson MA and Banks WA, Journal of Cerebral Blood Flow & Metabolism, 2013, 33, 1500– 1513. 23921899 PMC3790938
  44. [47]van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, Lammertsma AA and van Berckel BN, Molecular imaging and biology, 2012, 14, 771– 776. 22476967 PMC3492696
  45. [48]Tam RY, Fuehrmann T, Mitrousis N and Shoichet MS, Neuropsychopharmacology, 2014, 39, 169– 188. 24002187 PMC3857664
  46. [49]Teleanu DM, Chircov C, Grumezescu AM, Volceanov A and Teleanu RI, Pharmaceutics, 2018, 10, 269. PMC6321434 30544966
  47. [50]Kasinathan N, Jagani HV, Alex AT, Volety SM and Rao JV, Drug delivery, 2015, 22, 243– 257. 24471801
  48. [51]Teleanu DM, Chircov C, Grumezescu AM, Volceanov A and Teleanu RI, Journal of clinical medicine, 2018, 7, 490. PMC6306759 30486404
  49. [52]Mendes M, Sousa JJ, Pais A and Vitorino C, Pharmaceutics, 2018, 10, 181. PMC6321593 30304861
  50. [53]Teleanu DM, Negut I, Grumezescu V, Grumezescu AM and Teleanu RI, Nanomaterials, 2019, 9, 371. PMC6474019 30841578
  51. [54]Sarkar A, Fatima I, Mohammad Sajid Jamal Q, Sayeed U, Khan KA, Akhtar S, Amjad Kamal M, Farooqui A and Haris Siddiqui M, Current drug metabolism, 2017, 18, 129– 137. 28088890
  52. [55]Damkier HH, Brown PD and Praetorius J, Physiological reviews, 2013, 93, 1847– 1892. 24137023
  53. [56]Strazielle N and Ghersi-Egea J-F, Current pharmaceutical design, 2016, 22, 5463– 5476. 27464721 PMC5421134
  54. [57]Xu D-H, Yan M, Fang P-F and Liu Y-W, European journal of pharmacology, 2012, 690, 68– 76. 22749978
  55. [58]Khatoon M, Shah KU, Din FU, Shah SU, Rehman AU, Dilawar N and Khan AN, Drug delivery, 2017, 24, 56– 69. 29130758 PMC8812579
  56. [59]Lovisolo D, Dionisi M, Ruffinatti FA and Distasi C, AIMS Mol. Sci, 2018, 5, 1– 13.
  57. [60]Zhang C, Xie B, Zou Y, Zhu D, Lei L, Zhao D and Nie H, Advanced drug delivery reviews, 2018, 132, 33– 56. 29964080
  58. [61]Tosi G, Vandelli MA, Forni F and Ruozi B, Expert Opinion on Drug Delivery, 2015, 12, 1041– 1044. 25912814
  59. [62]Ramanathan S, Archunan G, Sivakumar M, Selvan ST, Fred AL, Kumar S, Gulyás B and Padmanabhan P, International journal of nanomedicine, 2018, 13, 5561– 5576. 30271147 PMC6154717
  60. [63]Kaushik AC, Bharadwaj S, Kumar S and Wei D-Q, Scientific reports, 2018, 8, 1– 8. 29907754 PMC6003935
  61. [64]Jin G-Z, Chakraborty A, Lee J-H, Knowles JC and Kim H-W, Journal of Tissue Engineering, 2020, 11, 2041731419897460. 32180936 PMC7057401
  62. [65]Sheikh S, Haque E and Mir SS, Journal of neurodegenerative diseases, 2013, 2013. PMC4437348 26316993
  63. [66]Ajnai G, Chiu A, Kan T, Cheng C-C, Tsai T-H and Chang J, Journal of Experimental & Clinical Medicine, 2014, 6, 172– 178.
  64. [67]Sanati M, Khodagholi F, Aminyavari S, Ghasemi F, Gholami M, Kebriaeezadeh A, Sabzevari O, Hajipour MJ, Imani M and Mahmoudi M, ACS chemical neuroscience, 2019, 10, 2299– 2309. 30933476
  65. [68]Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D and Namdee K, Scientific reports, 2019, 9, 1– 9. 31164665 PMC6547645
  66. [69]Talebpour F and Ghahghaei A, International Journal of Peptide Research and Therapeutics, 2020, 1– 10.
  67. [70]Gao N, Sun H, Dong K, Ren J and Qu X, Chemistry–A European Journal, 2015, 21, 829– 835. 25376633
  68. [71]Prades R, Guerrero S, Araya E, Molina C, Salas E, Zurita E, Selva J, Egea G, López-Iglesias C and Teixidó M, Biomaterials, 2012, 33, 7194– 7205. 22795856
  69. [72]Hsieh S, Chang C.-w. and Chou H.-h., Colloids and Surfaces B: Biointerfaces, 2013, 112, 525– 529. 24060166
  70. [73]Yoo J, Lee E, Kim HY, Youn D.-h., Jung J, Kim H, Chang Y, Lee W, Shin J and Baek S, Nature nanotechnology, 2017, 12, 1006– 1014. 28737745
  71. [74]Tang J, Xiong L, Zhou G, Wang S, Wang J, Liu L, Li J, Yuan F, Lu S and Wan Z, Journal of nanoscience and nanotechnology, 2010, 10, 6313– 6317. 21137724
  72. [75]Bony BA and Kievit FM, Pharmaceutics, 2019, 11, 473. PMC6781280 31540234
  73. [76]Lombardo D, Kiselev MA and Caccamo MT, Journal of Nanomaterials, 2019, 2019.
  74. [77]Huang C-L, Hsiao I-L, Lin H-C, Wang C-F, Huang Y-J and Chuang C-Y, Environmental research, 2015, 136, 253– 263. 25460644
  75. [78]Migliore L, Uboldi C, Di Bucchianico S and Coppedè F, Environmental and molecular mutagenesis, 2015, 56, 149– 170. 25627719
  76. [79]Manshadi MK, Saadat M, Mohammadi M, Shamsi M, Dejam M, Kamali R and Sanati-Nezhad A, Drug delivery, 2018, 25, 1963– 1973. 30799655 PMC6292362
  77. [80]Neuberger T, Schöpf B, Hofmann H, Hofmann M and Von Rechenberg B, Journal of Magnetism and Magnetic materials, 2005, 293, 483– 496.
  78. [81]Hadavi D and Poot AA, Frontiers in bioengineering and biotechnology, 2016, 4, 49. 27379232 PMC4909781
  79. [82]Ji W-H, Xiao Z-B, Liu G-Y and Zhang X, Chinese Chemical Letters, 2017, 28, 1829– 1834.
  80. [83]Chiellini F, Piras AM, Errico C and Chiellini E, Nanomedicine, 2008, 3, 367– 393. 18510431
  81. [84]Shakeri S, Ashrafizadeh M, Zarrabi A, Roghanian R, Afshar EG, Pardakhty A, Mohammadinejad R, Kumar A and Thakur VK, Biomedicines, 2020, 8, 13. PMC7168063 31941057
  82. [85]Cai Q, Wang L, Deng G, Liu J, Chen Q and Chen Z, American journal of translational research, 2016, 8, 749– 764. 27158367 PMC4846924
  83. [86]Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B and Emiliani C, Journal of functional biomaterials, 2019, 10, 4. PMC6463038 30626094
  84. [87]Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A and Préat V, Journal of controlled release, 2012, 161, 505– 522. 22353619
  85. [88]Kuo Y-C, Lin P-I and Wang C-C, Nanomedicine, 2011, 6, 1011– 1026. 21707298
  86. [89]Kuo Y-C and Tsai H-C, Materials Science and Engineering: C, 2018, 91, 445– 457. 30033276
  87. [90]Chen J, Zhang C, Liu Q, Shao X, Feng C, Shen Y, Zhang Q and Jiang X, Journal of drug targeting, 2012, 20, 174– 184. 21992548
  88. [91]Malmo J, Sandvig A, Vårum KM and Strand SP, PLoS One, 2013, 8, e54182. 23372682 PMC3553124
  89. [92]Cha C, Shin SR, Annabi N, Dokmeci MR and Khademhosseini A, ACS nano, 2013, 7, 2891– 2897. 23560817 PMC3648999
  90. [93]Liu J, Cui L and Losic D, Acta biomaterialia, 2013, 9, 9243– 9257. 23958782
  91. [94]Biju V, Chemical Society Reviews, 2014, 43, 744– 764. 24220322
  92. [95]Zhou K, Thouas GA, Bernard CC, Nisbet DR, Finkelstein DI, Li D and Forsythe JS, ACS applied materials & interfaces, 2012, 4, 4524– 4531. 22809168
  93. [96]Zhou K, Motamed S, Thouas GA, Bernard CC, Li D, Parkington HC, Coleman HA, Finkelstein DI and Forsythe JS, PLoS One, 2016, 11. PMC4792446 26978268
  94. [97]Mohajeri M, Behnam B, Barreto GE and Sahebkar A, Pharmacological research, 2019. 30943430
  95. [98]Hsieh F-Y, Zhilenkov A, Voronov I, Khakina E, Mischenko D, Troshin PA and Hsu S.-h., ACS applied materials & interfaces, 2017, 9, 11482– 11492. 28263053
  96. [99]Cellot G, Ballerini L, Prato M and Bianco A, Small, 2010, 6, 2630– 2633. 20859949
  97. [100]Singh B, Baburao C, Pispati V, Pathipati H, Muthy N, Prassana S and Rathode BG, International Journal of Research in Pharmacy and Chemistry, 2012, 2, 523– 532.
  98. [101]Dizaj SM, Mennati A, Jafari S, Khezri K and Adibkia K, Advanced pharmaceutical bulletin, 2015, 5, 19– 23. 25789215 PMC4352219
  99. [102]Komane PP, Choonara YE, du Toit LC, Kumar P, Kondiah PP, Modi G and Pillay V, Journal of Nanomaterials, 2016, 2016.
  100. [103]Cellot G, Cilia E, Cipollone S, Rancic V, Sucapane A, Giordani S, Gambazzi L, Markram H, Grandolfo M and Scaini D, Nature nanotechnology, 2009, 4, 126– 133. 19197316
  101. [104]Matsumoto K, Sato C, Naka Y, Kitazawa A, Whitby RL and Shimizu N, Journal of bioscience and bioengineering, 2007, 103, 216– 220. 17434423
  102. [105]Bokara KK, Kim JY, Lee YI, Yun K, Webster TJ and Lee JE, Anatomy & cell biology, 2013, 46, 85– 92. 23869255 PMC3713283
  103. [106]Hu B, Dai F, Fan Z, Ma G, Tang Q and Zhang X, Advanced Materials, 2015, 27, 5499– 5505. 26270904
  104. [107]Cheng KK, Chan PS, Fan S, Kwan SM, Yeung KL, Wang Y-XJ, Chow AHL, Wu EX and Baum L, Biomaterials, 2015, 44, 155– 172. 25617135
  105. [108]Fernández T, Martínez-Serrano A, Cussó L, Desco M and Ramos-Gómez M, ACS chemical neuroscience, 2018, 9, 912– 924. 29298040
  106. [109]Lu AH, Salabas E. e. L. and Schüth F, Angewandte Chemie International Edition, 2007, 46, 1222– 1244. 17278160
  107. [110]Chen T, Li C, Li Y, Yi X, Wang R, Lee SM-Y and Zheng Y, ACS applied materials & interfaces, 2017, 9, 9516– 9527. 28247754
  108. [111]Goel A, Howard JB and Vander Sande JB, Carbon, 2004, 42, 1907– 1915.
  109. [112]Silva GA, BMC neuroscience, 2008, 9, S4. PMC2604882 19091001
  110. [113]Grothe M, Heinsen H and Teipel S, Neurobiology of aging, 2013, 34, 1210– 1220. 23158764 PMC4058576
  111. [114]Ferris SH and Farlow M, Clinical interventions in aging, 2013, 8, 1007– 1014. 23946647 PMC3739421
  112. [115]Teleanu DM, Chircov C, Grumezescu AM and Teleanu RI, Pharmaceutics, 2019, 11, 101. PMC6471564 30813646
  113. [116]Xie J, Shen Z, Anraku Y, Kataoka K and Chen X, Biomaterials, 2019, 119491. 31546096 PMC6915305
  114. [117]Obermeyer JM, Tuladhar A, Payne SL, Ho E, Morshead CM and Shoichet MS, Tissue Engineering Part A, 2019, 25, 1175– 1187. 30612516
  115. [118]Chakroun RW, Zhang P, Lin R, Schiapparelli P, Quinones‐Hinojosa A and Cui H, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2018, 10, e1479. PMC5701865 28544801
  116. [119]Patel T, Zhou J, Piepmeier JM and Saltzman WM, Advanced drug delivery reviews, 2012, 64, 701– 705. 22210134 PMC3323692
  117. [120]Neeves KB, Sawyer AJ, Foley CP, Saltzman WM and Olbricht WL, Brain research, 2007, 1180, 121– 132. 17920047 PMC2169304
  118. [121]Kells AP, Hadaczek P, Yin D, Bringas J, Varenika V, Forsayeth J and Bankiewicz KS, Proceedings of the National Academy of Sciences, 2009, 106, 2407– 2411. PMC2650169 19193857
  119. [122]Yazdan-Shahmorad A, Diaz-Botia C, Hanson TL, Kharazia V, Ledochowitsch P, Maharbiz MM and Sabes PN, Neuron, 2016, 89, 927– 939. 26875625
  120. [123]Yazdan-Shahmorad A, Tian N, Kharazia V, Samaranch L, Kells A, Bringas J, He J, Bankiewicz K and Sabes PN, Journal of neuroscience methods, 2018, 293, 347– 358. 29042259
  121. [124]Masserini M, ISRN biochemistry, 2013, 238428, 18. PMC4392984 25937958
  122. [125]Silva Adaya D, Aguirre-Cruz L, Guevara J and Ortiz-Islas E, Journal of biomaterials applications, 2017, 31, 953– 984. 28178902
  123. [126]Rahaman ST, World Journal of Pharmaceutical Sciences, 2018, 6, 153– 169.
  124. [127]Johnsen KB, Bak M, Kempen PJ, Melander F, Burkhart A, Thomsen MS, Nielsen MS, Moos T and Andresen TL, Theranostics, 2018, 8, 3416– 3436. 29930740 PMC6010987
  125. [128]Toccaceli G, Barbagallo G and Peschillo S, Theranostics, 2019, 9, 537– 539. 30809291 PMC6376189
  126. [130]Jagannathan J, Sanghvi NT, Crum LA, Yen C-P, Medel R, Dumont AS, Sheehan JP, Steiner L, Jolesz F and Kassell NF, Neurosurgery, 2009, 64, 201– 211. 19190451 PMC4068031
  127. [131]Jang HJ, Lee J-Y, Lee D-H, Kim W-H and Hwang JH, Gut and liver, 2010, 4, S57. 21103296 PMC2989544
  128. [132]Curley CT, Sheybani ND, Bullock TN and Price RJ, Theranostics, 2017, 7, 3608– 3623. 29109764 PMC5667336
  129. [133]Jordão JF, Ayala-Grosso CA, Markham K, Huang Y, Chopra R, McLaurin J, Hynynen K and Aubert I, PloS one, 2010, 5, e10549. 20485502 PMC2868024
  130. [134]Raymond SB, Treat LH, Dewey JD, McDannold NJ, Hynynen K and Bacskai BJ, PloS one, 2008, 3, e2175. 18478109 PMC2364662
  131. [135]Wang F, Shi Y, Lu L, Liu L, Cai Y, Zheng H, Liu X, Yan F, Zou C and Sun C, PLoS One, 2012, 7, e52925. 23300823 PMC3531370
  132. [136]Qin Y, Chen H, Zhang Q, Wang X, Yuan W, Kuai R, Tang J, Zhang L, Zhang Z and Zhang Q, International journal of pharmaceutics, 2011, 420, 304– 312. 21945185
  133. [137]Kuai R, Yuan W, Qin Y, Chen H, Tang J, Yuan M, Zhang Z and He Q, Molecular pharmaceutics, 2010, 7, 1816– 1826. 20701288
  134. [138]Zheng C, Ma C, Bai E, Yang K and Xu R, International journal of clinical and experimental medicine, 2015, 8, 1658– 1668. 25932094 PMC4402741
  135. [139]Madani F, Lindberg S, Langel Ü, Futaki S and Gräslund A, Journal of biophysics, 2011, 2011. PMC3103903 21687343
  136. [140]Bechara C and Sagan S, FEBS letters, 2013, 587, 1693– 1702. 23669356
  137. [141]Eugenin EA, Clements JE, Zink MC and Berman JW, Journal of Neuroscience, 2011, 31, 9456– 9465. 21715610 PMC3132881
  138. [143]Nowak M, Helgeson ME and Mitragotri S, Advanced Therapeutics, 2020, 3, 1900073.
  139. [144]Wen X, Wang K, Zhao Z, Zhang Y, Sun T, Zhang F, Wu J, Fu Y, Du Y and Zhang L, PLoS One, 2014, 9, e106652. 25187980 PMC4154764
  140. [145]Masuda H, Hirata A, Kawai H, Wake K, Watanabe S, Arima T, Poulletier de Gannes F, Lagroye I and Veyret B, Journal of Applied Physiology, 2011, 110, 142– 148. 21030669
  141. [147]Jones RM, Deng L, Leung K, McMahon D, O’Reilly MA and Hynynen K, Theranostics, 2018, 8, 2909– 2926. 29896293 PMC5996357
  142. [148]Sun Z, Worden M, Wroczynskyj Y, Yathindranath V, van Lierop J, Hegmann T and Miller DW, International journal of nanomedicine, 2014, 9, 3013– 3026. 25018630 PMC4073976
  143. [149]Kievit FM and Zhang M, Accounts of chemical research, 2011, 44, 853– 862. 21528865 PMC3192288
  144. [150]Xu C and Sun S, Advanced drug delivery reviews, 2013, 65, 732– 743. 23123295

Cited by

Sorted by citations

Related

Authors
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M.
Affiliations
  • The Department of Environmental Science & Engineering
  • The University of Texas at El Paso (US)
  • The Department of Chemistry
Corresponding author
Narayan, Mahesh
ORCID
Venue
Biomaterials Science
Publisher
Royal Society of Chemistry (RSC)
Published
2020
Volume
8
Issue
15
Pages
4109-4128
ISSN
  • 2047-4830 (ISSN-L)
  • 2047-4849
DOI
10.1039/d0bm00809e
PMC
PMC7439575
OpenAlex
W3036295808
Cited by
181
References
153
Citations by year
2026: 19 · 2025: 27 · 2024: 53 · 2023: 37 · 2022: 26 · 2021: 19
FWCI
5.33
Type
journal article
Language
en
Open access
Licence
rsc.li/journals-terms-of-use (am, 538 d)
Locations
  • Biomaterials Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (1SC3 GM111200 01A1)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
nanomaterials, drug delivery systems, neurodegenerative diseases, blood-brain barrier, blood-CSF barrier, P-glycoprotein, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington's disease, prion disease, nanoparticles, magnetic nanoparticles, polymeric nanoparticles, carbon nanoparticles, cell-penetrating peptides, receptor-mediated transcytosis, blood-brain barrier disruption, local drug delivery
MeSH terms
Aged, Blood-Brain Barrier, Humans, Drug Delivery Systems, Neurodegenerative Diseases, Nanotechnology, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review